Stuart G. MacKay and Nicholas W. Stow
Abstract: Following the publication of a randomized controlled trial (RCT) of adenotonsillectomy (TA) for obstructive sleep apnea (OSA) in 464 children aged 5 to 9 years [1], some discussion has been inaccurately negative in regards to interpretation of the study’s findings [2]. This commentary seeks to explore the misinterpretations and highlight the critical strengths and limitations of the RCT in question.
No comments:
Post a Comment